Delivery Order SPE2DB24D2106-SPE2DB25FAURK

Award Date 2/26/25
Potential Completion Date 3/19/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the supply of FASENRA PEN 30 MG/MLML, a pharmaceutical product. This delivery order is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $7,330.50, is for the delivery of FASENRA PEN 30 MG/MLML, a pharmaceutical product, with a completion date of May 20, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with DLA, valued up to $499,999,999, which allows the agency to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $31,765.50, is for the delivery of a specific pharmaceutical product, FASENRA 30 MG/ML SYRINGEML, and has a completion date of June 6, 2024. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and...
This is a delivery order under a Defense Logistics Agency (DLA) prime vendor contract with DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,443.50 firm fixed-price delivery order is for the pharmaceutical product FASENRA PEN 30 MG/ML. The contract has no set-aside designation and supports the recurring medical supply needs of military health facilities under the DLA Medical Supply Chain program. DMS Pharmaceutical Group holds a $499,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,443.50, is for the delivery of FASENRA 30 MG/ML SYRINGEML, a specialized pharmaceutical product. The contract has a period of performance through March 21, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,443.50, is for the delivery of FASENRA 30 MG/ML syringe. The contract has an ultimate completion date of March 23, 2023. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This firm fixed-price delivery order worth $2,443.50 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of FASENRA 30 MG/ML SYRINGEML, a specialty medication, with a completion date of September 9, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the delivery of FASENRA PEN 30 MG/MLML. The award is a delivery order under an existing indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999. This single-award IDC, under the SPE2DB program, allows...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $29,322.00 firm fixed-price contract is for the delivery of FASENRA 30 MG/ML SYRINGEML, a prescription pharmaceutical product, with a performance period through May 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the provision of FASENRA 30 MG/ML SYRINGEML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAURK
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $2,275.00 and an ultimate completion date of March 19, 2025.

The contract is for the delivery of FASENRA PEN 30 MG/MLML, a pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 5/28/25, 11:00 AM